Yahoo
    Shanghai - Delayed Quote CNY

    Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)

    33.16 -0.11 (-0.33%)
    At close: 3:00:02 PM GMT+8
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for 688336.SS
    • Previous Close 33.27
    • Open 33.57
    • Bid 33.16 x --
    • Ask 33.18 x --
    • Day's Range 33.09 - 34.10
    • 52 Week Range 30.65 - 66.62
    • Volume 3,416,125
    • Avg. Volume 7,215,652
    • Market Cap (intraday) 29.719B
    • Beta (5Y Monthly) 0.47
    • PE Ratio (TTM) 9.64
    • EPS (TTM) 3.44
    • Earnings Date --
    • Forward Dividend & Yield 0.49 (1.48%)
    • 1y Target Est 55.12
    • Moby Rating Neutral

    Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs. Its products include Enbrel, a recombinant human type II tumor necrosis factor receptor-antibody fusion protein for the treatment of autoimmune rheumatism and immunology; Jiannipa, a recombinant anti-CD25 humanized monoclonal antibody injection to prevent acute rejection caused by kidney transplantation; and Enbrel, an anti-IL-17A humanized monoclonal antibody ambroxol injection for the treatment of moderate to severe plaque psoriasis. The company was founded in 2002 and is based in Shanghai, China.

    3s-guojian.com

    1,012

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Biotechnology

    Industry

    More about Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

    YTD Return

    688336.SS
    18.24%
    SSE Composite Index (000001.SS)
    7.76%

    1-Year Return

    688336.SS
    25.33%
    SSE Composite Index (000001.SS)
    8.42%

    3-Year Return

    688336.SS
    109.18%
    SSE Composite Index (000001.SS)
    19.90%

    5-Year Return

    688336.SS
    168.40%
    SSE Composite Index (000001.SS)
    4.39%

    Analyst Insights

    View More

    Analyst Price Targets

    55.12
    55.12 Average
    33.16 Current
    55.12 High

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell
    View More

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      68.99%

    • Return on Assets (ttm)

      22.93%

    • Return on Equity (ttm)

      42.58%

    • Revenue (ttm)

      4.48B

    • Net Income Avi to Common (ttm)

      3.09B

    • Diluted EPS (ttm)

      3.44

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      1.6B

    • Total Debt/Equity (mrq)

      --

    • Levered Free Cash Flow (ttm)

      -1.17B

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    688578.SS Shanghai Allist Pharmaceuticals Co., Ltd.
    85.10 -2.71%
    688266.SS Suzhou Zelgen Biopharmaceuticals Co., Ltd.
    90.21 -0.65%
    688180.SS Shanghai Junshi Biosciences Co., Ltd.
    30.96 +0.36%
    300558.SZ Betta Pharmaceuticals Co., Ltd.
    46.77 -1.20%
    688321.SS Shenzhen Chipscreen Biosciences Co., Ltd.
    21.00 -0.57%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: